| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711578 | Annals of Allergy, Asthma & Immunology | 2018 | 28 Pages |
Abstract
Topical corticosteroid, elimination diet, and dilation are the current treatment modalities for confirmed EoE. The use of proton-pump inhibitors (PPI) is being suggested as a potential regimen to treat EoE, based on evolving understanding of PPI-responsive esophageal eosinophilia (PPI-REE). The complexity of EoE treatment regimens and frequent follow-ups require a multimodal, multi-disciplinary management approach to optimize patient care.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Quan M. MD, PhD, Seema S. MD, PhD,